Not all mutations are equal in their impact on cancer. Some mutations, known as driver mutations, directly contribute to cancer development and progression. Others, known as passenger mutations, do not contribute to cancer but occur alongside driver mutations. Identifying driver mutations is crucial for developing effective targeted therapies.
